Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Quest Diagnostics Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Quest Diagnostics Incorporated May 20, 202699.6%
-
Pentair plc. May 5, 202699.8%
-
Quest Diagnostics Incorporated May 15, 202599.6%
-
Quest Diagnostics Incorporated May 16, 202499.5%
-
Pentair plc. May 7, 202499.7%
-
Quest Diagnostics Incorporated May 17, 202399.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Quest Diagnostics Incorporated | Grant or award | +1,142 | — | — |
| Jan 2, 2026 | Pentair plc. | Grant or award | +1,564 | — | — |
| Jan 2, 2026 | Pentair plc. | Shares withheld for tax | −688 | $105.47 | $72,563 |
| May 15, 2025 | Quest Diagnostics Incorporated | Grant or award | +1,203 | — | — |
| Jan 2, 2025 | Pentair plc. | Grant or award | +1,643 | — | — |
| Jan 2, 2025 | Pentair plc. | Shares withheld for tax | −985 | $100.40 | $98,894 |
| Aug 31, 2024 | Pentair plc. | Shares withheld for tax | −865 | $86.47 | $74,797 |
| May 16, 2024 | Quest Diagnostics Incorporated | Grant or award | +1,482 | — | — |
| Jan 2, 2024 | Pentair plc. | Grant or award | +2,256 | — | — |
| Aug 31, 2023 | Pentair plc. | Grant or award | +2,135 | — | — |
| May 17, 2023 | Quest Diagnostics Incorporated | Grant or award | +1,369 | — | — |
Questions about Tracey Doi
What boards is Tracey Doi on?
Tracey Doi sits on the boards of Pentair plc. and Quest Diagnostics Incorporated.
How long has Tracey Doi served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.